ACAD

ACADIA Pharmaceuticals · USD

Market closed US (NYSE / Nasdaq) · 09:30–16:00 · Sun 20:41 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About ACADIA Pharmaceuticals

ACADIA Pharmaceuticals (ACAD) is a biopharmaceutical company focused on discovering and developing novel therapies for central nervous system disorders, though specific product details are not widely publicized. Without more recent information, its sector primarily falls under pharmaceuticals.

Ticker	ACAD
Name	ACADIA Pharmaceuticals
Currency	USD

Reputation

🙂

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

good bad neutral

Daily open/high/low/close candles with volume bars beneath; hover a candle for its OHLC, change and volume. Dots mark analysed news coloured by sentiment. Pick a range, or click-and-drag across the chart to zoom in.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BULLISH

61.66

RSI (14)i

21.41

SMA 20i

21.79

SMA 50i

23.47

SMA 200i

0.00%

1di

0.19%

1wi

-4.43%

1mi

2.04%

30d voli

28.06

52w highi

20.06

52w lowi

-23.16%

from highi

-0.10

MACDi

Downtrend (50d below 200d)MACD bullish crossover

Computed from 252 locally-stored price bars.

AI signals

HOLD 70% · long_term 2026-06-07 23:29

The stock has been in a consolidation phase with minor fluctuations around the $21.56 level, indicating indecision among investors. The recent close at $21.56 is very close to its opening price of $21.43 on June 3rd, suggesting that buyers and sellers are evenly matched. Without any significant positive news or catalysts in the headlines, this setup leans towards a neutral stance with some caution.

qwen2.5:3b